BR9706142A - Compostos substituídos por sulfonamida processos para a sua preparação seu emprego como medicamento ou diagnóstico e os preparados farmacêuticos contendo os mesmos - Google Patents
Compostos substituídos por sulfonamida processos para a sua preparação seu emprego como medicamento ou diagnóstico e os preparados farmacêuticos contendo os mesmosInfo
- Publication number
- BR9706142A BR9706142A BR9706142A BR9706142A BR9706142A BR 9706142 A BR9706142 A BR 9706142A BR 9706142 A BR9706142 A BR 9706142A BR 9706142 A BR9706142 A BR 9706142A BR 9706142 A BR9706142 A BR 9706142A
- Authority
- BR
- Brazil
- Prior art keywords
- nme2
- ome
- nhso2me
- so2me
- so2nh2
- Prior art date
Links
- 125000000565 sulfonamide group Chemical group 0.000 title abstract 7
- 229940124530 sulfonamide Drugs 0.000 title abstract 2
- 150000001875 compounds Chemical group 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 8
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 abstract 7
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 7
- -1 NEt2 Chemical group 0.000 abstract 6
- 229910006074 SO2NH2 Inorganic materials 0.000 abstract 6
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 abstract 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 6
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 229910002091 carbon monoxide Inorganic materials 0.000 abstract 5
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 5
- 229910052717 sulfur Inorganic materials 0.000 abstract 5
- 125000001544 thienyl group Chemical group 0.000 abstract 4
- 125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 abstract 3
- 125000002883 imidazolyl group Chemical group 0.000 abstract 3
- 125000004076 pyridyl group Chemical group 0.000 abstract 3
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 2
- 125000002947 alkylene group Chemical group 0.000 abstract 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 2
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 abstract 2
- 101001043818 Mus musculus Interleukin-31 receptor subunit alpha Proteins 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000005956 isoquinolyl group Chemical group 0.000 abstract 1
- 125000005493 quinolyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- NVBFHJWHLNUMCV-UHFFFAOYSA-N sulfamide Chemical class NS(N)(=O)=O NVBFHJWHLNUMCV-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/16—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with only hydrogen or carbon atoms directly attached in positions 2 and 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Quinoline Compounds (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1996152213 DE19652213A1 (de) | 1996-12-16 | 1996-12-16 | Sulfonamid-substituierte Verbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE1997130326 DE19730326A1 (de) | 1997-07-15 | 1997-07-15 | Sulfonamid-substituierte Verbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9706142A true BR9706142A (pt) | 1999-05-18 |
Family
ID=26032247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9706142A BR9706142A (pt) | 1996-12-16 | 1997-12-15 | Compostos substituídos por sulfonamida processos para a sua preparação seu emprego como medicamento ou diagnóstico e os preparados farmacêuticos contendo os mesmos |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US5856338A (pt) |
| EP (1) | EP0847996B1 (pt) |
| JP (1) | JP4317601B2 (pt) |
| KR (1) | KR19980064151A (pt) |
| CN (1) | CN1185435A (pt) |
| AT (1) | ATE234821T1 (pt) |
| AU (1) | AU725699B2 (pt) |
| BR (1) | BR9706142A (pt) |
| CA (1) | CA2224885A1 (pt) |
| CZ (1) | CZ403997A3 (pt) |
| DE (1) | DE59709560D1 (pt) |
| DK (1) | DK0847996T3 (pt) |
| ES (1) | ES2195071T3 (pt) |
| HR (1) | HRP970684A2 (pt) |
| HU (1) | HUP9702475A3 (pt) |
| ID (1) | ID19152A (pt) |
| IL (1) | IL122576A0 (pt) |
| NO (1) | NO975887L (pt) |
| NZ (1) | NZ329200A (pt) |
| PL (1) | PL323809A1 (pt) |
| PT (1) | PT847996E (pt) |
| SI (1) | SI0847996T1 (pt) |
| SK (1) | SK171797A3 (pt) |
| TR (1) | TR199701605A2 (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9711220D0 (en) * | 1997-05-30 | 1997-07-23 | Isis Innovation | Antiarrhythmic agents |
| DE19858253A1 (de) * | 1998-12-17 | 2000-06-21 | Aventis Pharma Gmbh | Verwendung von Inhibitoren des KQt1-Kanals zur Herstellung eines Medikaments zur Behandlung von Krankheiten, die durch Helminthen und Ektoparasiten hervorgerufen werden |
| US7183075B2 (en) | 2000-04-14 | 2007-02-27 | Vanderbilt University | Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| TWI357901B (en) * | 2004-03-12 | 2012-02-11 | Lundbeck & Co As H | Substituted morpholine and thiomorpholine derivati |
| CN113402476B (zh) * | 2021-06-21 | 2022-04-19 | 广东湛江海洋医药研究院 | 一种亚胺噁嗪衍生物及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3737195A1 (de) * | 1987-11-03 | 1989-05-18 | Bayer Ag | Chromanderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| GB8808069D0 (en) * | 1988-04-07 | 1988-05-11 | Fujisawa Pharmaceutical Co | Benzopyran derivatives & processes for preparation thereof |
| FR2639349B1 (fr) * | 1988-11-23 | 1991-02-22 | Sanofi Sa | Nouveaux derives du chromane actifs sur le systeme nerveux central, leur procede de preparation et les compositions pharmaceutiques en contenant |
| US5104890A (en) * | 1989-03-28 | 1992-04-14 | Fujisawa Pharmaceutical Company, Ltd. | Benzopyran derivatives and processes for preparation thereof |
| WO1994004521A1 (fr) * | 1992-08-17 | 1994-03-03 | Chugai Seiyaku Kabushiki Kaisha | Derives de benzopyranne et de benzoxazine |
| TR199700369A2 (xx) * | 1996-05-15 | 1997-12-21 | Hoechst Ag | S�lfonamid ile s�bstit�e edilmi� kroman'lar, bunlar�n �retilmesine mahsus usul, ila� veya diyagnostik olarak kullan�lmalar� ve bunlar� i�eren ila�. |
-
1997
- 1997-11-18 NZ NZ329200A patent/NZ329200A/xx unknown
- 1997-12-05 PT PT97121437T patent/PT847996E/pt unknown
- 1997-12-05 AT AT97121437T patent/ATE234821T1/de not_active IP Right Cessation
- 1997-12-05 DK DK97121437T patent/DK0847996T3/da active
- 1997-12-05 EP EP97121437A patent/EP0847996B1/de not_active Expired - Lifetime
- 1997-12-05 DE DE59709560T patent/DE59709560D1/de not_active Expired - Lifetime
- 1997-12-05 SI SI9730534T patent/SI0847996T1/xx unknown
- 1997-12-05 ES ES97121437T patent/ES2195071T3/es not_active Expired - Lifetime
- 1997-12-11 ID IDP973864A patent/ID19152A/id unknown
- 1997-12-12 SK SK1717-97A patent/SK171797A3/sk unknown
- 1997-12-12 IL IL12257697A patent/IL122576A0/xx unknown
- 1997-12-12 TR TR97/01605A patent/TR199701605A2/xx unknown
- 1997-12-15 AU AU48373/97A patent/AU725699B2/en not_active Ceased
- 1997-12-15 JP JP34546997A patent/JP4317601B2/ja not_active Expired - Fee Related
- 1997-12-15 NO NO975887A patent/NO975887L/no not_active Application Discontinuation
- 1997-12-15 BR BR9706142A patent/BR9706142A/pt not_active Application Discontinuation
- 1997-12-15 CZ CZ974039A patent/CZ403997A3/cs unknown
- 1997-12-15 HR HR19730326.9A patent/HRP970684A2/hr not_active Application Discontinuation
- 1997-12-15 CN CN97125504A patent/CN1185435A/zh active Pending
- 1997-12-15 HU HU9702475A patent/HUP9702475A3/hu unknown
- 1997-12-15 US US08/990,455 patent/US5856338A/en not_active Expired - Lifetime
- 1997-12-16 PL PL97323809A patent/PL323809A1/xx unknown
- 1997-12-16 CA CA002224885A patent/CA2224885A1/en not_active Abandoned
- 1997-12-16 KR KR1019970068995A patent/KR19980064151A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| AU725699B2 (en) | 2000-10-19 |
| CA2224885A1 (en) | 1998-06-16 |
| JPH10182610A (ja) | 1998-07-07 |
| NO975887D0 (no) | 1997-12-15 |
| MX9710126A (es) | 1998-07-31 |
| PT847996E (pt) | 2003-07-31 |
| CZ403997A3 (cs) | 1998-07-15 |
| HU9702475D0 (en) | 1998-03-02 |
| SK171797A3 (en) | 1998-07-08 |
| DE59709560D1 (de) | 2003-04-24 |
| HUP9702475A3 (en) | 2000-01-28 |
| EP0847996A1 (de) | 1998-06-17 |
| AU4837397A (en) | 1998-06-18 |
| HUP9702475A2 (hu) | 1999-06-28 |
| SI0847996T1 (en) | 2003-08-31 |
| JP4317601B2 (ja) | 2009-08-19 |
| CN1185435A (zh) | 1998-06-24 |
| EP0847996B1 (de) | 2003-03-19 |
| NO975887L (no) | 1998-06-17 |
| ATE234821T1 (de) | 2003-04-15 |
| US5856338A (en) | 1999-01-05 |
| TR199701605A2 (xx) | 1998-07-21 |
| KR19980064151A (ko) | 1998-10-07 |
| HRP970684A2 (en) | 1998-10-31 |
| ES2195071T3 (es) | 2003-12-01 |
| DK0847996T3 (da) | 2003-06-30 |
| PL323809A1 (en) | 1998-06-22 |
| ID19152A (id) | 1998-06-18 |
| NZ329200A (en) | 1999-05-28 |
| IL122576A0 (en) | 1998-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3677452D1 (de) | Chinazolinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| ES2192394T3 (es) | Profarmacos de inhibidores de la bomba de protones. | |
| ATE239680T1 (de) | Sulfonamid derivate und deren verwendung | |
| FI831604L (fi) | Pyridinderivat, deras framstaellning och anvaendning | |
| DK0579496T3 (da) | 4-Aminoquinazolinderivater og deres anvendelse som lægemidler | |
| DK148392D0 (da) | Heterocykliske forbindelser | |
| DZ1694A1 (fr) | "n-(2-Aminoethyl)-benzothialozones". | |
| KR950700321A (ko) | 혈소판 응집 억제제로서의 4-옥소-2-티옥소이미다졸리딘 유도체(4-Oxo-2-thioxoimidazolidine derivatives as inhibitors of blood platelet aggregation) | |
| BR9706142A (pt) | Compostos substituídos por sulfonamida processos para a sua preparação seu emprego como medicamento ou diagnóstico e os preparados farmacêuticos contendo os mesmos | |
| PT90912A (pt) | Processo para a preparacao de derivados de tiofenol | |
| DK0599240T3 (da) | Indol-7-carboxamidderivater som analgetika | |
| AR241182A1 (es) | Un procedimiento para preparar n-(2-metoxifenil)-piperazinil-alcanoil anilidas. | |
| ES531063A0 (es) | Procedimiento para la preparacion de un nuevo compuesto heterociclico | |
| DE3687675D1 (de) | Substituierte toluidine, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer. | |
| AR015140A1 (es) | N-(3,4-dihidro-2h-piran-4-il)sulfonamidas, procedimiento para su preparacion, su utilizacion para la preparacion de un medicamento, un preparadofarmaceutico y medicamento | |
| EA200400666A3 (ru) | Новые соединения бензотиазина и бензотиадиазина, способ их получения и фармацевтические композиции, которые их содержат | |
| SE8400628D0 (sv) | Mitomycin analogs | |
| ATE117674T1 (de) | Sulfonamide enthaltende arzneimittel, neue sulfonamide und verfahren zu ihrer herstellung. | |
| AR013133A1 (es) | Un compuesto de metaloceno en puente, un procedimiento para prepararlo, un ligando, un sistema catalizador para la polimerizacion de olefinas, unprocedimiento para la polimerizacion de olefinas, y un procedimiento para la oligomerizacion de olefinas | |
| TH1033A (th) | การใช้ไนโตร อะมิโน และเอโรอิลอะมิโน-n- เฟนนิลพิริดีนอะมีนในกรรมวิธีการเตรียมสารพิริโด [1,4] -เบนโซไดอะซิฟินซึพีนต่าง ๆ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |